Quant Biomarkers
The AI engine Fit Assessment
BetaQuant Biomarkers leverages machine learning for pattern discovery and therapeutic target identification, focusing on personalized biomarker development.
Blurb
Operator of a biotechnology research firm intended to focus on the development and application of quantitative biomarkers.
HQ Location
Basel (Switzerland)
Founded
2021
Employees
1 - 10
Total funding raised
Not available
Last Funding Event
Not available
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
- Biomarker Identification
Operator of a biotechnology research firm intended to focus on the development and application of quantitative biomarkers. The company uses a combination of artificial intelligence, machine learning and advanced biological science to analyze large datasets of clinical data and identify patterns that can be used to predict health outcomes and identify potential therapeutic targets, enabling people to live longer, healthier lives by identifying and addressing potential health risks.